Another important factor reinforcing the segment's dominance is doctors' confidence in GLP-1 treatments for the treatment of diabetes
When researchers talk about GHK-CU peptide benefits, they are usually referring to studies involving skin quality, collagen production, tissue repair pathways, and hair follicle research
Today, fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isnt serious enough for treatment, said David A Ricks, chair and CEO of Eli Lilly, in a statement
Imaging mass spectrometry at cellular length scales
It generally works really well